The announcement of our partnership with SOAS, University of London, a renowned school of social sciences, for a joint PhD in development studies, marks a significant milestone for private ...

The draft guidance, which is touted as a way to reduce the cost and time-associated burden of biosimilar development, has ...

A new full-time scholarship will be available for early childhood undergraduates at SUSS from July 2027. Read more at ...

Challenging a long-standing assumption regarding the adult brain, recent research has demonstrated that individuals can ...

The US Food and Drug Administration (FDA) has announced major steps to make it faster and less costly to develop biosimilar ...

Resilience has, in the past four decades, been a term increasingly employed throughout a number of sciences: psychology and ecology, most prominently. Increasingly one finds it in political science, ...

The Shanghai Cooperation Organization Tianjin Summit, which convened on Aug 31 and Sept 1, marked the beginning of a new ...

LSEG is a leading global financial markets infrastructure and data provider. Through its Islamic Finance division, LSEG delivers market intelligence, Sharīʿah-compliant indices, data analytics, and ...

By emphasizing analytical studies instead of routine clinical trials, the FDA signals its intent to reduce the cost (often estimated at $100 million to $300 million) and time (typically 6–9 years) ...

Camino Minerals Corporation (TSXV:COR)(OTCID:CAMZF) ("Camino" or the "Company") is pleased to announce that its joint venture ...

The FDA today unveiled a plan to accelerate development of biosimilars in hopes of significantly reducing drug costs in the United States.The agency issued draft guidance that would simplify the study ...

For years, K-12 schools have grouped English learners in classrooms, driven by factors including limited resources and the ...